We did not find any association between GLP-1 RA use and a higher risk of HF hospitalization or CV death, and rather the trend was towards a lower risk (P-value: 0.07), mainly driven by a statistically significant association with a 36% lower risk of CV death. The gene discussed is GLP1R; the disease is hydrops fetalis.